Omnicef the most effective medicine for ear infections
This study presented at the International Society of quality of Life demonstrated that children taking Omnicef drug were 28 percent more likely to finish all their medication than those taking Augmentin antibiotic. Parents regarded generic Omnicef a significantly effective, easier-to-use medicine in the antibiotic list to treat acute otitis media.
In this study, researchers compared the safety and efficacy of Omnicef antibiotic to Augmentin oral drug and analyzed more than 360 parent- reported outcomes considering various attributes of the Omnicef and Augmentin medication. Parents rated the overall response to the prescription antibiotics on several criteria including, how their children tolerated the medicine, satisfaction, overall compliance, and work or daycare missed as a result of the infection.
In the study Omnicef oral antibiotics were indicated for pediatric patients (ages six months to 12 years) who did not have systemic treatment with any antibiotic drug seven days prior to this study. Parents reported that Omnicef medicine was a significantly better tasting and well tolerated and children taking Omnicef drug were half as likely to vomit after administration than children taking Augmentin antibiotic.
The primary study results were previously presented at the Pediatric Infectious Disease Society Conference in October 2003. The main goal of this study was to compare the clinical effectiveness of the two treatment regimens: Omnicef drug twice-a-day for five days to Augmentin antibiotic twice-a-day for 10 days for acute otitis media, a bacterial infection of the ear. Omnicef medicine prescribed twice daily for five days was shown to be as effective as generic Augmentin administered twice daily for 10 days.
This Phase IV trial was a randomized, fundamental study of 425 pediatric patients having a diagnosis of acute otitis media. The distribution of patients was similar in respect to demographics, pretreatment conditions and severity of pretreatment signs and symptoms. Both of the antibiotic medicines had a well tolerated profile and the same incidence of adverse reactions.
“Compliance with therapy disturbs effectively treating the infection and preventing the spread of antibiotic drugs resistance,” said Mary Cifaldi, Ph.D., assistant director of Global Health Economics and Outcomes Research, Abbott Laboratories. “This study demonstrates that Omnicef’s five-day dosing and good strawberry taste make it easier for children to take their medicine in accordance with prescription antibiotics.”
